1.Toxicological Profi le of Hexane Extract of Alpinia conchigera (Small Ginger) In vitro
Ahmad Rohi Ghazali ; Fazrina Hamzah ; Norizah Awang ; Wan Marahaini Wan Razali
Malaysian Journal of Health Sciences 2015;13(1):69-76
Alpinia conchigera (small ginger) is a herbaceous plant that is usually used as an alternative treatment in the fi eld of
traditional medicine. This study was conducted to evaluate the cytotoxicity, genotoxicity and mode of cell death of hexane
extract of A. conchigera towards Chang liver cells. The 24 hours MTT assay as carried out to determine the viability
percentage of Chang liver cells after being treated with hexane extract of A. conchigera. The results showed that there
was a signifi cant decrease in cell viability (p < 0.05) and IC50 value of hexane extract of A. conchigera was 8.6 μg/ml
compared to negative control. Based on this IC50 value, AO/PI staining was done to determine the mode of cell death in
liver Chang cells by means of apoptosis or necrosis. The results showed that there was a signifi cant change (p < 0.05)
for mode of Chang liver cells death through apoptosis compared to negative control. In this study, the evaluation of DNA
damage was also done using alkaline comet assay. The IC10 and IC25 values of 4 μg/ml and 6 μg/ml respectively that were
obtained in MTT assay were used. Chang liver cells were treated with A. conchigera hexane extract for 2 hours. There
was a signifi cant change (p < 0.05) for percentage of DNA damage in treated group compared to negative control. As a
conclusion, hexane extract of A. conchigera gave cytotoxic and genotoxic effect towards Chang liver cells as well as to
induce cell death through apoptosis.
Cytotoxins
2.11 Cases of Aspergillosis.
Ho Won HWANG ; Jang Shin SOHN ; Chae Hong SUH
Korean Journal of Pathology 1985;19(3):325-331
Genus of aspergilli are ubiquitous saprophytic molds in nature, which are recognized about 700 species, at least eight are pathologic for human. Pulmonary aspergillosis is rare disease, most frequent presenting as secondary invasion, and aspergillosis of the nasal cavity is the most common sites of the extrapulmonary aspergillosis. Predisposing factors for pulmonary aspergillosis are chronic lung disease, tuberculosis, antibiotics, cytotoxins and neoplasia, hematologic disorders, and histoplasmosis etc. Authors have experienced 10 cases of pulmonary aspergillosis and a case of aspergillosis of nasal cavity in Dept. of Pathol. Chosun univ. hospital and christian hospital from Feb. 1981 to July 1984. Patient of pulmonary aspergillosis are received surgical resection and survived well without complications.
Humans
;
Cytotoxins
3.Target Therapy for Colorectal Cancer.
Yeungnam University Journal of Medicine 2006;23(2):143-151
In the past decade, the median duration of survival among patients with advanced colorectal cancer has increased from 12 months to about 18 months, primarily as a results of the introduction of irinotecan and oxaliplatin. Advances in the understanding of the molecular mechanisms underlying the development and progression of cancer have resulted in the discovery of new therapeutic interventions that target specific molecular abnormalities. Their specificity, and therefore their potential to bind preferentially and modify tumor-specific targets, sparing normal tissues and causing fewer side-effects compared to conventional cytotoxic agents, makes them an attractive therapeutic option. The future of this approach for the treatment of solid tumors is promising
Colorectal Neoplasms*
;
Cytotoxins
;
Humans
4.Target Therapy for Colorectal Cancer.
Yeungnam University Journal of Medicine 2006;23(2):143-151
In the past decade, the median duration of survival among patients with advanced colorectal cancer has increased from 12 months to about 18 months, primarily as a results of the introduction of irinotecan and oxaliplatin. Advances in the understanding of the molecular mechanisms underlying the development and progression of cancer have resulted in the discovery of new therapeutic interventions that target specific molecular abnormalities. Their specificity, and therefore their potential to bind preferentially and modify tumor-specific targets, sparing normal tissues and causing fewer side-effects compared to conventional cytotoxic agents, makes them an attractive therapeutic option. The future of this approach for the treatment of solid tumors is promising
Colorectal Neoplasms*
;
Cytotoxins
;
Humans
7.Recent treatment of pancreatic cancer.
Korean Journal of Medicine 2009;77(6):695-702
Pancreatic cancer has a high mortality rate and short survival as a result of the high incidence of metastatic disease at diagnosis, the fatal clinical course, and the lack of successful therapeutic strategies. Gemcitabine remains the only standard of care for this disease. Increasing combination therapies containing gemcitabine have been tested or are undergoing investigation. In the last decade, despite a number of clinical trials assessing novel cytotoxic agents and cell signaling inhibitors, the overall survival has reached a plateau that remains difficult to improve on. This review presents recent developments involving newer chemotherapeutic and molecular targeted agents, and identifies efforts for individualized treatment strategies.
Cytotoxins
;
Deoxycytidine
;
Incidence
;
Pancreatic Neoplasms
;
Standard of Care
8.Recent treatment of pancreatic cancer.
Korean Journal of Medicine 2009;77(6):695-702
Pancreatic cancer has a high mortality rate and short survival as a result of the high incidence of metastatic disease at diagnosis, the fatal clinical course, and the lack of successful therapeutic strategies. Gemcitabine remains the only standard of care for this disease. Increasing combination therapies containing gemcitabine have been tested or are undergoing investigation. In the last decade, despite a number of clinical trials assessing novel cytotoxic agents and cell signaling inhibitors, the overall survival has reached a plateau that remains difficult to improve on. This review presents recent developments involving newer chemotherapeutic and molecular targeted agents, and identifies efforts for individualized treatment strategies.
Cytotoxins
;
Deoxycytidine
;
Incidence
;
Pancreatic Neoplasms
;
Standard of Care
9.Investigation on anti-microorganism and cytotoxic properties of alkaloids from some species of Crinum in Vietnam
Pharmaceutical Journal 2003;234(4):18-21
Investigation on anti-microorganism and cytotoxic properties of alkaloids from Crinum latigolium L. and Crinu asiaticum L. (Amaryllidaceae) growing in Vietnam and seven pure alkaloids from these plants. The total alkaloids from C.latifolium L. and C. asiaticum L/ showed a strong effect against Sarcina lutea while pratorinine was found to be active against Staphylococcus aureus. Among the evaluated alkaloids, lycorine showed a very strong cytotoxic activity on Hep-G2, RD and Fi and 1-O-acetyl – lycorine exhibited a moderate activity on Hep-G2. The remaining alkaloids were found not to be cytotoxic in all tested cell lines.
Alkaloids
;
Cytotoxins
;
Crinum
;
Anti-Bacterial Agents
10.Targeted therapy and immunotherapy in ovarian cancer.
Journal of the Korean Medical Association 2016;59(3):180-188
Epithelial ovarian cancer is one of the last treatment areas to be influenced by the 'personalized medicine' bandwagon. Some anti-angiogenic agents, poly (ADP-ribose) polymerase (PARP), and immune checkpoint inhibitors have shown efficacy in early stages of development for the treatment of epithelial ovarian cancer. As a result of vigorous clinical trials, bevacizumab, cediranib, pazopanib, olaparib, and rucaparib, either used alone or in adjunct to conventional cytotoxic agents, have all been shown to improve progression-free survival in first-line/maintenance, platinum-resistant or sensitive recurrent settings. A biomarker for bevacizumab is currently elusive. Olaparib is the first drug approved for the treatment of high-grade serous tumors and requires routine testing for BRCA mutation. Trial results of PARP inhibitors in the homologous recombination-deficient (non BRCA mutation) population are awaited and the introduction of these agents into the clinic will require robust methods of detecting homologous recombination-deficiency. Second-generation studies combining anti-angiogenic agents with PARP inhibitors are in progress and early results in the recurrent setting are encouraging. Trials with immune checkpoint inhibitors such as nivolumab produced prolonged responses in a small set of ovarian cancer cases and need further exploration, for example in combination with anti-angiogenic agents. The application of targeted agents and immunologics, alone or in combination, to induce a survival advantage in patients with epithelial ovarian cancer should be continued.
Bevacizumab
;
Cytotoxins
;
Disease-Free Survival
;
Humans
;
Immunotherapy*
;
Ovarian Neoplasms*